Johnson & Johnson Innovation team up with Manchester scientists

As part of a strategy to explore the emerging science around the human microbiome and its impact across several areas of health and disease, Johnson & Johnson Consumer & Personal Products Worldwide and Johnson & Johnson Innovation have established a collaboration with scientists from The University of Manchester.

The collaboration will explore potential applications of probiotic extracts for prevention and treatment of skin, oral, and respiratory conditions.

Dr Catherine O’Neill, from the University’s Institute of Inflammation and Repair, and Dr Andrew McBain, from Manchester Pharmacy School, will lead on the research project with Johnson & Johnson Innovation.

Dr O’Neill said: “It’s exciting to be working with such a massive global player who we hope will really help us to develop products which will bring benefits to patients.

“This collaboration will help us co-develop a piece of technology established here in Manchester which uses probiotics – or friendly bacteria - on the skin and hopefully take this to market.”

The agreement underscores the approach Johnson & Johnson Innovation is taking to establish scientific collaborations in areas that span its pharmaceutical, medical device and diagnostics and consumer businesses.

ENDS

Notes for editors

For further information, please contact Alison Barbuti, Media Relations Officer, Faculty of Medical and Human Sciences

Tel: +44 (0)161 275 8383 / Mob. 07887 561 318